QT Prolongation and Torsades de pointes associated with clarithromycin treatment

被引：0

作者：

Caccavo, Alberto ^{[1
]}

Keegan, Roberto ^{[2
]}

机构：

[1] Hosp Municipal & Clin Coronel Suarez, Coronel Suarez, Argentina

[2] Hosp Privado Sur, Bahia Blanca, Buenos Aires, Argentina

来源：

REVISTA DE LA FEDERACION ARGENTINA DE CARDIOLOGIA | 2016年 / 45卷 / 03期

关键词：

Clarithromycin; Long QT; Torsades de pointes;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Woman of 66 years of age that while being treated with clarithromycin, for a respiratory infection, developed ventricular tachycardia and torsades de pointes with long QT. After the suspension of the drug the QT was normalized and the patient evolved without events during 3 years. We warn on the potential adverse effect of QT prolongation and potentially fatal arrhythmias associated with the intake of clarithromycin, especially in groups with risk factors.

引用

页码：149 / 150

页数：2

共 14 条

[1] MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia
Abbott, GW
Sesti, F
Splawski, I
Buck, ME
Lehmann, WH
Timothy, KW
Keating, MT
Goldstein, SAN
[J]. CELL, 1999, 97 (02) : 175 - 187
[2] Clarithromycin-Induced Torsades de Pointes
Chang, Nai-Lun
Shah, Priyank
Bikkina, Mahesh
Shamoon, Fayez
[J]. AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (03) : e955 - e956
[3] Torsades de pointes following clarithromycin treatment
Gysel, Michael
Vieweg, W. Victor R.
Hasnain, Mehrul
Hancox, Jules C.
Kunanithy, Vitharani
Baranchuk, Adrian
[J]. EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2013, 11 (11) : 1485 - 1493
[4] Torsades de Pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia
Hayashi, Y
Ikeda, U
Hashimoto, T
Watanabe, T
Mitsuhashi, T
Shimada, K
[J]. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1999, 22 (04): : 672 - 674
[5] Clarithromycin induced torsade de pointes
Hensey, C.
Keane, D.
[J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2008, 177 (01) : 67 - 68
[6] Clarithromycin associated with torsades de pointes
Kamochi, H
Nii, T
Eguchi, K
Mori, T
Yamamoto, A
Shimoda, K
Ibaraki, K
[J]. JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1999, 63 (05): : 421 - 422
[7] Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]
[8] QT prolongation and Torsades de pointes associated with clarithromycin
Lee, KL
Jim, MH
Tang, SC
Tai, YT
[J]. AMERICAN JOURNAL OF MEDICINE, 1998, 104 (04) : 395 - 396
[9] Oral erythromycin and the risk of sudden death from cardiac causes
Ray, WA
Murray, KT
Meredith, S
Narasimhulu, SS
Hall, K
Stein, CM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) : 1089 - 1096
[10] Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies
Schembri, Stuart
Williamson, Peter A.
Short, Philip M.
Singanayagam, Aran
Akram, Ahsan
Taylor, Joanne
Singanayagam, Anika
Hill, Adam T.
Chalmers, James D.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2013, 346

← 1 2 →